Pharmacodynamic and pharmacokinetic effects and safety of verinurad in combination with allopurinol in adults with gout: a phase IIa, open-label study.

Fleischmann, Roy; Winkle, Peter; Miner, Jeffrey N; Yan, Xiaohong; Hicks, Liz; Valdez, Shakti; Hall, Jesse; Liu, Sha; Shen, Zancong; Gillen, Michael; Hernandez-Illas, Martha

Fleischmann, Roy; Winkle, Peter; Miner, Jeffrey N; Yan, Xiaohong; Hicks, Liz; Valdez, Shakti; Hall, Jesse; Liu, Sha; Shen, Zancong; Gillen, Michael; Hernandez-Illas, Martha.

Affiliation

Fleischmann R; Metroplex Clinical Research Center, University of Texas, SW Medical Center, Dallas, Texas, USA.
Winkle P; Anaheim Clinical Trials, Anaheim, California, USA.
Miner JN; Ardea Biosciences, San Diego, California, USA.
Yan X; Ardea Biosciences, San Diego, California, USA.
Hicks L; Ardea Biosciences, San Diego, California, USA.
Valdez S; Ardea Biosciences, San Diego, California, USA.
Hall J; Ardea Biosciences, San Diego, California, USA.
Liu S; Metroplex Clinical Research Center, University of Texas, SW Medical Center, Dallas, Texas, USA.
Shen Z; Anaheim Clinical Trials, Anaheim, California, USA.
Gillen M; Ardea Biosciences, San Diego, California, USA.
Hernandez-Illas M; AstraZeneca LP, Gaithersburg, Maryland, USA.

RMD Open ; 4(1): e000584, 2018.

Article in En | MEDLINE | ID: mdl-29531784

Key words

gout; pharmacokinetics; treatment

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: RMD Open Year: 2018 Document type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google